Zhongsheng pharmaceutical compound Xueshuantong capsule obtained clinical approval for increasing function
-
Last Update: 2014-09-13
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
As a private pharmaceutical enterprise dominated by traditional Chinese medicine, Zhongsheng pharmaceutical has a good growth trend in its main business and a broad market space for its core varieties At present, the price of raw materials is the main constraint on the company's profitability Therefore, the company is actively carrying out industry M & A and seeking to extend its industrial chain upstream The current indications of the company's compound Xueshuantong capsule are retinal vein occlusion in the syndrome of blood stasis and deficiency of Qi and Yin, and stable and tired angina pectoris in the syndrome of blood stasis and deficiency of Qi and Yin The drug approval documents further enrich the company's product categories, show the company's strong R & D strength, and help to optimize the company's product structure and enhance the company's core competitiveness.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
